Kick-Nic! App for Quitting Vaping
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new app called Kick-Nic!, designed to help high school students quit vaping. Participants will either use the app or be referred to a website to determine which method aids more in quitting. The trial seeks high school students who use e-cigarettes with nicotine at least once a week and want to quit. Participants need a smartphone with internet access to use the app. The trial will monitor participants for several months to assess the app's effectiveness. As a Phase 2 trial, this research focuses on evaluating the app's effectiveness in an initial, smaller group, offering participants a chance to contribute to important findings.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, if you have been using anxiolytics, antidepressants, or other psychostimulants for less than 2 months, you may not be eligible to participate.
What prior data suggests that the Kick-Nic! app is safe for high school students?
Research has shown that digital tools like the Kick-Nic! app are generally safe for users. Studies on similar apps for quitting vaping have found that people use them without problems. Unlike some medications, these apps don't cause physical side effects. Most user feedback focuses on the app's ease of use and design, rather than safety issues.
The Kick-Nic! app is currently in a Phase 2 trial, indicating that earlier studies suggested it is safe enough for testing with more people. This phase examines user responses to the app, including any possible side effects. So far, no major safety issues have been reported for digital tools like this one.12345Why are researchers excited about this trial?
Researchers are excited about the Kick-Nic! app because it offers a fresh, tech-driven approach to quitting vaping. Unlike traditional methods that often involve counseling or nicotine replacement therapies, Kick-Nic! uses a mobile app to engage users directly on their phones, making it easily accessible and potentially more engaging. This digital approach can personalize quitting strategies, providing tailored support and motivation, which might enhance success rates for those trying to quit vaping. Additionally, the app's convenience and ability to provide real-time feedback and progress tracking are features that set it apart from other cessation methods.
What evidence suggests that the Kick-Nic! app is effective for vaping cessation?
Studies have shown that digital tools, like apps, offer a promising way to help young people quit vaping. In this trial, participants in the active group will access the Kick-Nic! app, designed specifically for high school students who want to stop vaping. Research indicates that similar app-based programs have successfully helped people quit temporarily and adhere to their quitting plans. Early results suggest these digital tools can engage users and help them stay focused. By providing personalized support and resources, the Kick-Nic! app aims to make quitting vaping easier for teens.12367
Who Is on the Research Team?
Suchitra Krishnan-Sarin, Ph.D.
Principal Investigator
Yale University School of Medicine, Dept of Psychiatry
Are You a Good Fit for This Trial?
This trial is for high school students who are currently vaping and want to quit. They must be willing to participate in an 8-week program and attend follow-up visits up to 6 months after the treatment period. The study excludes individuals who do not meet these criteria.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the Kick-Nic! app or are referred to the NCI Quit Vaping website for an 8-week period
Follow-up
Participants are monitored for safety and effectiveness after treatment with follow-up visits at 1, 2, 3, and 6 months
What Are the Treatments Tested in This Trial?
Interventions
- Kick-Nic!
Find a Clinic Near You
Who Is Running the Clinical Trial?
Yale University
Lead Sponsor
National Cancer Institute (NCI)
Collaborator